Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.

Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF.

Nat Genet. 1999 Sep;23(1):32-40.

PMID:
10471495
2.

The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.

Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G.

J Clin Invest. 1999 Aug;104(3):357-64.

3.

Deconstructing type 2 diabetes.

Taylor SI.

Cell. 1999 Apr 2;97(1):9-12. Review. No abstract available.

4.

Insulin-stimulated insulin secretion in single pancreatic beta cells.

Aspinwall CA, Lakey JR, Kennedy RT.

J Biol Chem. 1999 Mar 5;274(10):6360-5.

5.
6.

Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1.

Krempler F, Hell E, Winkler C, Breban D, Patsch W.

Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1686-90.

8.

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Shepherd PR, Withers DJ, Siddle K.

Biochem J. 1998 Aug 1;333 ( Pt 3):471-90. Review. Erratum in: Biochem J 1998 Nov 1;335(Pt 3):711.

9.
11.

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA.

Endocr Rev. 1998 Jun;19(3):225-68. Review.

PMID:
9626554
12.

Disruption of IRS-2 causes type 2 diabetes in mice.

Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF.

Nature. 1998 Feb 26;391(6670):900-4.

PMID:
9495343
13.

The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.

White MF, Yenush L.

Curr Top Microbiol Immunol. 1998;228:179-208. Review. No abstract available.

PMID:
9401207
15.

Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice.

Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR.

J Clin Invest. 1997 Dec 1;100(11):2729-36.

16.

Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells.

Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF.

Diabetes. 1997 Jun;46(6):1087-93.

17.

Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.

Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T.

J Clin Invest. 1997 Mar 1;99(5):861-6.

18.

Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.

Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR.

Cell. 1997 Feb 21;88(4):561-72.

19.

The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action.

Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers MG Jr, Glasheen E, Copeland NG, Jenkins NA, Pierce JH, White MF.

Mol Endocrinol. 1997 Feb;11(2):251-62.

PMID:
9013772
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk